BSE Live
Jan 02, 09:55Prev. Close
73.59
Open Price
73.01
Bid Price (Qty.)
72.91 (228)
Offer Price (Qty.)
73.60 (15)
NSE Live
Jan 02, 09:52Prev. Close
73.02
Open Price
71.25
Bid Price (Qty.)
73.21 (118)
Offer Price (Qty.)
73.77 (2)
| Profit & Loss account of Bal Pharma (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 108.15 | 106.55 | 90.35 | 76.18 | 74.62 | |
| Less: Excise/Sevice Tax/Other Levies | 2.25 | 3.08 | 4.61 | 5.38 | 7.12 | |
| Revenue From Operations [Net] | 105.90 | 103.48 | 85.74 | 70.81 | 67.50 | |
| Total Operating Revenues | 105.90 | 103.48 | 85.74 | 70.81 | 67.50 | |
| Other Income | 2.74 | 0.02 | 0.07 | -0.16 | 0.96 | |
| Total Revenue | 108.64 | 103.49 | 85.80 | 70.65 | 68.46 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 63.78 | 45.12 | 36.13 | 32.51 | 30.98 | |
| Purchase Of Stock-In Trade | 3.74 | 10.11 | 9.21 | 4.68 | 3.56 | |
| Operating And Direct Expenses | 2.15 | 1.37 | 1.46 | 1.43 | 1.17 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -4.53 | 0.89 | 0.05 | -1.72 | 0.70 | |
| Employee Benefit Expenses | 16.72 | 20.64 | 15.41 | 12.35 | 10.86 | |
| Finance Costs | 5.66 | 3.93 | 2.73 | 2.68 | 2.51 | |
| Depreciation And Amortisation Expenses | 2.81 | 1.83 | 1.58 | 1.42 | 1.18 | |
| Other Expenses | 19.29 | 14.94 | 15.07 | 13.34 | 12.86 | |
| Total Expenses | 109.59 | 99.41 | 82.08 | 67.42 | 64.43 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -0.94 | 4.09 | 3.72 | 3.23 | 4.03 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | -0.94 | 4.09 | 3.72 | 3.23 | 4.03 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.00 | 0.16 | 0.74 | 0.34 | 0.30 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.46 | 0.78 | 0.31 | 0.66 | 0.04 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 0.47 | 1.18 | 1.23 | 1.15 | 0.57 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -1.41 | 2.91 | 2.49 | 2.08 | 3.46 | |
| Profit/Loss From Continuing Operations | -1.34 | 3.00 | 2.79 | 2.02 | 2.93 | |
| Profit/Loss For The Period | -1.34 | 3.00 | 2.79 | 2.02 | 2.93 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | -1.28 | 2.86 | 2.67 | 1.93 | 2.80 | |
| Diluted EPS (Rs.) | -1.28 | 2.86 | 2.67 | 1.93 | 2.80 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 19.55 | 19.26 | 16.66 | 12.73 | 11.71 | |
| Indigenous Raw Materials | 36.14 | 18.07 | 12.86 | 12.48 | 12.71 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 1.05 | 0.86 | 0.83 | 1.00 | 0.98 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.79 | 1.04 | 0.78 | 0.78 | |
| Tax On Dividend | 0.00 | 0.13 | 0.18 | 0.13 | 0.11 | |
| Equity Dividend Rate (%) | 0.00 | 8.00 | 10.00 | 8.00 | 8.00 |
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y
19.11.2025
Bal Pharma Consolidated September 2025 Net Sales at Rs 74.02 crore, up 0.45% Y-o-Y
13.11.2025
Bal Pharma Standalone September 2025 Net Sales at Rs 73.75 crore, down 1.27% Y-o-Y
09.09.2025
Bal Pharma Standalone June 2025 Net Sales at Rs 65.64 crore, down 10.25% Y-o-Y
10.06.2025
Bal Pharma Standalone March 2025 Net Sales at Rs 81.78 crore, down 13.53% Y-o-Y